EE200000179A - 1-oxa, aza and thianaphthalene-2-1 biseters as phospholambane inhibitors - Google Patents
1-oxa, aza and thianaphthalene-2-1 biseters as phospholambane inhibitorsInfo
- Publication number
- EE200000179A EE200000179A EEP200000179A EEP200000179A EE200000179A EE 200000179 A EE200000179 A EE 200000179A EE P200000179 A EEP200000179 A EE P200000179A EE P200000179 A EEP200000179 A EE P200000179A EE 200000179 A EE200000179 A EE 200000179A
- Authority
- EE
- Estonia
- Prior art keywords
- phospholambane
- biseters
- thianaphthalene
- aza
- oxa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93711997A | 1997-09-24 | 1997-09-24 | |
| US99015097A | 1997-12-12 | 1997-12-12 | |
| US10411498A | 1998-06-25 | 1998-06-25 | |
| PCT/FI1998/000755 WO1999015523A1 (en) | 1997-09-24 | 1998-09-24 | Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200000179A true EE200000179A (en) | 2001-04-16 |
| EE04494B1 EE04494B1 (en) | 2005-06-15 |
Family
ID=27379660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000179A EE04494B1 (en) | 1997-09-24 | 1998-09-24 | 1-Oxa, aza and thianaphthalen-2-one biseters as phospholambane inhibitors |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1017691A1 (en) |
| JP (1) | JP2003525838A (en) |
| KR (1) | KR20010015607A (en) |
| CN (1) | CN1143857C (en) |
| AU (1) | AU735729B2 (en) |
| BR (1) | BR9813216A (en) |
| CA (1) | CA2304849A1 (en) |
| EA (1) | EA003084B1 (en) |
| EE (1) | EE04494B1 (en) |
| HU (1) | HUP0003647A3 (en) |
| ID (1) | ID24373A (en) |
| IL (1) | IL134662A0 (en) |
| NO (1) | NO20001569D0 (en) |
| NZ (1) | NZ503044A (en) |
| PL (1) | PL339493A1 (en) |
| SK (1) | SK3902000A3 (en) |
| TR (1) | TR200000764T2 (en) |
| WO (1) | WO1999015523A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4890723B2 (en) * | 2000-07-21 | 2012-03-07 | 中外製薬株式会社 | Coumarin derivatives useful as TNFα inhibitors |
| KR100586138B1 (en) * | 2001-03-30 | 2006-06-07 | 화이자 프로덕츠 인코포레이티드 | Pyridazinone aldose reductase inhibitors |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| FR2970964B1 (en) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | NOVEL AZACOUMARIN DERIVATIVES WITH INHIBITOR ACTIVITY OF MDR PUMPS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543945A1 (en) * | 1975-10-02 | 1977-04-21 | Troponwerke Gmbh & Co Kg | Coronary dilator 2-benzopyranones, active by enteral admin. - contg. trimethoxybenzoyl or trimethoxycinnamoyl substits. |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8630702D0 (en) * | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
| US5053514A (en) * | 1988-08-10 | 1991-10-01 | Otsuka Pharmaceutical Company, Limited | Cardiotonics |
| CA2022236A1 (en) * | 1989-07-31 | 1991-02-01 | Hiroaki Yanagisawa | Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders |
| DE4337906A1 (en) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Use of coumarin derivatives |
-
1998
- 1998-09-24 IL IL13466298A patent/IL134662A0/en unknown
- 1998-09-24 CA CA002304849A patent/CA2304849A1/en not_active Abandoned
- 1998-09-24 TR TR2000/00764T patent/TR200000764T2/en unknown
- 1998-09-24 ID IDW20000564A patent/ID24373A/en unknown
- 1998-09-24 EP EP98946482A patent/EP1017691A1/en not_active Withdrawn
- 1998-09-24 SK SK390-2000A patent/SK3902000A3/en unknown
- 1998-09-24 NZ NZ503044A patent/NZ503044A/en unknown
- 1998-09-24 AU AU93508/98A patent/AU735729B2/en not_active Ceased
- 1998-09-24 BR BR9813216-4A patent/BR9813216A/en not_active IP Right Cessation
- 1998-09-24 KR KR1020007003094A patent/KR20010015607A/en not_active Application Discontinuation
- 1998-09-24 JP JP2000512828A patent/JP2003525838A/en active Pending
- 1998-09-24 EE EEP200000179A patent/EE04494B1/en not_active IP Right Cessation
- 1998-09-24 EA EA200000352A patent/EA003084B1/en not_active IP Right Cessation
- 1998-09-24 PL PL98339493A patent/PL339493A1/en unknown
- 1998-09-24 CN CNB98809438XA patent/CN1143857C/en not_active Expired - Fee Related
- 1998-09-24 WO PCT/FI1998/000755 patent/WO1999015523A1/en not_active Application Discontinuation
- 1998-09-24 HU HU0003647A patent/HUP0003647A3/en unknown
-
2000
- 2000-03-24 NO NO20001569A patent/NO20001569D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9813216A (en) | 2000-08-29 |
| HUP0003647A3 (en) | 2002-12-28 |
| KR20010015607A (en) | 2001-02-26 |
| EE04494B1 (en) | 2005-06-15 |
| NO20001569L (en) | 2000-03-24 |
| PL339493A1 (en) | 2000-12-18 |
| EP1017691A1 (en) | 2000-07-12 |
| EA003084B1 (en) | 2002-12-26 |
| NZ503044A (en) | 2001-08-31 |
| AU9350898A (en) | 1999-04-12 |
| ID24373A (en) | 2000-07-13 |
| CN1143857C (en) | 2004-03-31 |
| IL134662A0 (en) | 2001-04-30 |
| WO1999015523A1 (en) | 1999-04-01 |
| JP2003525838A (en) | 2003-09-02 |
| EA200000352A1 (en) | 2000-10-30 |
| SK3902000A3 (en) | 2000-12-11 |
| AU735729B2 (en) | 2001-07-12 |
| TR200000764T2 (en) | 2001-03-21 |
| CN1271357A (en) | 2000-10-25 |
| HUP0003647A2 (en) | 2001-08-28 |
| CA2304849A1 (en) | 1999-04-01 |
| NO20001569D0 (en) | 2000-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200175A (en) | Substituted 2-Thio-3,5-Dicyano-4-aryl-6-aminopyridines and their Uses | |
| PT904774E (en) | RESORCINOL DERIVATIVES | |
| NO983187L (en) | Substituted aza and diazacycloheptane and cyclooctane compound and their use | |
| EE04500B1 (en) | Thrombin inhibitors, their preparation and use | |
| NO982686D0 (en) | R ° rledningsplugg | |
| EE200100373A (en) | Benzoheterocycles and their use as MEK inhibitors | |
| DE69837355D1 (en) | Bola | |
| DK1027332T3 (en) | New lactametalloprotease inhibitors | |
| DK0958287T3 (en) | Sulfamidmetalloprotease inhibitors | |
| EE9900006A (en) | Novel amidine derivatives and their use as thrombin inhibitors | |
| EE9900600A (en) | Novel amidine derivatives and their use as thrombin inhibitors | |
| EE04721B1 (en) | Phenylxanthine derivatives, processes for their preparation and use | |
| EE200000621A (en) | Anti-picornaviral compounds, their preparation and use | |
| TR199800117A3 (en) | Isaksazol- and crotonacitamide derivatives and their use. | |
| NO984662D0 (en) | Water-in-oil emulsjonsgj ° dningsstoffsammensetninger | |
| PT1023268E (en) | ISOKINOLINES AS UROQUINASE INHIBITORS | |
| NO20003142L (en) | Substituted isoquinoline derivatives and their use as anticonvulsants | |
| DE69811367D1 (en) | CIS-SUBSTITUTED FLUOROMETHYLPYRROLIDINE DERIVATIVES | |
| NO995653D0 (en) | Cis-substituted aminocycloalkyl-pyrrolidine derivatives | |
| NO974175L (en) | B ° lgekraftverk | |
| EE200000179A (en) | 1-oxa, aza and thianaphthalene-2-1 biseters as phospholambane inhibitors | |
| FI974212A0 (en) | Isolator | |
| ID26780A (en) | COMPOUNDS, TIENOPIRIDINA, THEIR RESULTS AND USE | |
| BR9707943B (en) | COMPOUND AND GLUTARIMIDE | |
| NO974892L (en) | Ventilasjonsr ° r |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20050924 |